secwatch.observer — SEC 8-K summary
======================================

Issuer:     AiXin Life International, Inc. (AIXN)
CIK:        0000835662
Form:       8-K
Filed at:   2022-12-01T23:59:59+00:00
Accession:  0001493152-22-034190
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aixin Life appoints Tianfeng Li as CFO and Jiao Huiliang to Board
-----------------------------------------------------------------

- Tianfeng Li appointed CFO effective Dec 1, 2022; base salary $26,000 annually.
- Li previously Finance Manager at subsidiary Chengdu Aixin Pharmacy since May 2019.
- Li replaces Guolu Li, who had served as CFO since February 2017.
- Jiao Huiliang added to board; background includes CEO roles and 40+ health-food patents.
- Huiliang holds a pharmacy degree from China Pharmaceutical University and has experience in functional products.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/835662/000149315222034190/0001493152-22-034190-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/835662/000149315222034190/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-034190

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer